We continue to strengthen our internal breast milk marketing practices while adhering to the WHO Code of Marketing of Breastmilk Substitutes (BMS) as implemented by national governments and The Infant Milk Substitutes, Feeding Bottles and Infant Foods Act, 1992, as amended in 2003 (IMS Act). This act regulates the production, supply and distribution of infant formula in India in compliance with our Nestlé Policy and Instructions for Implementation of the WHO Code, which is considered stricter than national legislations.
In 2016, our BMS marketing practices were assessed by ATNI India Index, which reported, “With respect to BMS marketing, Nestlé India demonstrated a high level of compliance with the Indian IMS Act and the Code. Nestlé India, like Nestlé S.A., is an industry leader with respect to committing to providing facilities that support breastfeeding mothers at work.”
We were the first BMS manufacturer included in the FTSE4Good Responsible Investment Index and have met its rigorous criteria for marketing of BMS since 2011.
Find out more about our Global Commitments at